ENDRA Life Sciences (NASDAQ:NDRA) Shares Down 4.8% – Time to Sell?

ENDRA Life Sciences Inc. (NASDAQ:NDRAGet Free Report)’s share price fell 4.8% on Friday . The company traded as low as $4.33 and last traded at $4.33. 7,406 shares traded hands during mid-day trading, a decline of 58% from the average session volume of 17,815 shares. The stock had previously closed at $4.55.

ENDRA Life Sciences Stock Down 4.8 %

The stock has a market cap of $2.34 million, a price-to-earnings ratio of 0.00 and a beta of 0.50. The stock has a fifty day moving average of $5.46 and a two-hundred day moving average of $279.65.

ENDRA Life Sciences Company Profile

(Get Free Report)

ENDRA Life Sciences Inc develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion.

Read More

Receive News & Ratings for ENDRA Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ENDRA Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.